Molecular Linkage between Atherosclerosis and Extracellular Vesicles
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 1300
Special Issue Editor
Special Issue Information
Dear Colleagues,
Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries, leading to narrowing and thrombosis that cause mortality. Atherosclerosis affects younger people and is involved in the majority of deaths worldwide. Vascular inflammation contributes to atherogenesis by activation of the molecular and cellular pathways and plays a critical role in causing atherosclerosis plaques to become unstable and rupture, leading to a stroke or myocardial infarction. The molecular mechanisms associated with thrombotic complications of atherosclerosis have evolved much beyond the ‘vulnerable plaque’ concept. Extracellular vesicles (EVs), like exosomes, are small, lipid bilayer-enclosed structures secreted by endothelial cells, immune cells and other cardiovascular tissues. They are associated with key steps in atherosclerosis, including endothelial dysfunction and vascular wall inflammation resulting in vascular remodeling. EVs inherit bioactive components from parent cells and are able to transfer their contents to recipient cells. EVs regulate gene expression in recipient cells by carrying mRNA, miRNA, proteins and bioactive molecules between cells. EV microRNAs are key players in cardiac regeneration and have cardioprotective and regenerative properties that influence cardiac and non-cardiac cells as well as stem and progenitor cells. Therefore, EVs are valuable prognostic and diagnostic biomarkers and therapeutic targets in cardiovascular diseases.
Dr. Wioletta Olejarz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atherosclerosis
- extracellular vesicles
- exosomes
- vascular inflammation
- stroke
- biomarkers
- miRNA
- stem and progenitor cells
- cardiovascular diseases
